Skip to Content
Merck
  • The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.

The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.

Scientific reports (2017-03-10)
Jung-Chun Lin, Yuan-Chii Lee, Yu-Chih Liang, Yang C Fann, Kory R Johnson, Ying-Ju Lin
ABSTRACT

A growing body of studies has demonstrated that dysregulated splicing profiles constitute pivotal mechanisms for carcinogenesis. In this study, we identified discriminative splicing profiles of colorectal cancer (CRC) cells compared to adjacent normal tissues using deep RNA-sequencing (RNA-seq). The RNA-seq results and cohort studies indicated a relatively high ratio of exon 4-excluded neuro-oncological ventral antigen 1 (Nova1